Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies.
Fatma Mohamed ElsenosyGhada Ahmed AbdelbaryAhmed Hassen ElshafeeyIbrahim ElsayedAhmed Roshdy FaresPublished in: International journal of nanomedicine (2020)
Accordingly, intranasal DLX in situ cubo-gel can be considered as an innovative nano-carrier delivery system for bioavailability enhancement and efficient brain targeting of DLX to maximize its effect.